Chemed Corp: Form 10-Q for the period ended Mar 31, 2015
Filed with the SEC on May 1, 2015 and accepted by EDGAR at May 1, 2015, 08:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-01-01 to 2015-03-31 | $376.7m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-01-01 to 2015-03-31 | $268.9m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2015-01-01 to 2015-03-31 | $58.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-01-01 to 2015-03-31 | $40.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-01-01 to 2015-03-31 | $969.0k | us-gaap:InterestExpense |
| Income tax | 3 months2015-01-01 to 2015-03-31 | $15.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-01-01 to 2015-03-31 | $24.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-01-01 to 2015-03-31 | $1.40 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-01-01 to 2015-03-31 | $1.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-01-01 to 2015-03-31 | 17,466,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2015-01-01 to 2015-03-31 | $12.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2015-01-01 to 2015-03-31 | $8.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2015-01-01 to 2015-03-31 | $3.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2015-03-31 | $28.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-03-31 | $208.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-03-31 | $895.7m | us-gaap:Assets |
| Current liabilities | At period end2015-03-31 | $171.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-03-31 | $419.1m | us-gaap:Liabilities |
| Long-term debt | At period end2015-03-31 | $154.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-03-31 | $6.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-03-31 | $476.5m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-03-31 | 17,077,227 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-15-001512. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.